IVME — In Veritas Medical Diagnostics Income Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.03m
- $5.26m
Annual income statement for In Veritas Medical Diagnostics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2003 July 31st | 2004 July 31st | C2005 July 31st | C2006 July 31st | 2007 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB/A | 10KSB/A | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.286 | 0.761 | 0.88 | 1.27 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.278 | 0.76 | 0.875 | 1.27 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.37 | 1.78 | 2.76 | 2.37 | 2.72 |
Operating Profit | -1.08 | -1.02 | -1.88 | -1.09 | -2.72 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.08 | -1.02 | -2.45 | -1.84 | -3.67 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.08 | -1.02 | -2.45 | -1.84 | -3.67 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.08 | -1.02 | -2.45 | -1.84 | -3.67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.08 | -1.02 | -2.45 | -1.84 | -3.67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.099 | -0.086 | -0.046 | -0.033 | -0.062 |
Dividends per Share |